Patents Assigned to TECHNOLOGIES BIOLACTIS INC.
  • CHEMOTHERAPEUTIC AGENTS AS ANTI-CANCER VACCINE ADJUVANTS AND THERAPEUTIC METHODS THEREOF
    Publication number: 20100272676
    Abstract: The present invention relates to an anti-cancer vaccine composition comprising an antigen in association with an effective amount of at least one immunomodulator chemotherapeutic adjuvant eliciting an immune response in a patient and a pharmaceutically acceptable carrier. It also relates to method of preventing tumor growth and reducing tumor growth using the anti-cancer vaccine composition of the present invention.
    Type: Application
    Filed: April 2, 2010
    Publication date: October 28, 2010
    Applicant: TECHNOLOGIES BIOLACTIS INC.
    Inventors: Éric Simard, Philippe Goyette, Pierre Lemieux